Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Minda Liu"'
Autor:
Jiachen Yu, Yuting Liu, Yingchun Zhang, Rong Ran, Zixiao Kong, Duoyi Zhao, Minda Liu, Wei Zhao, Yan Cui, Yingqi Hua, Lianbo Gao, Zhiyu Zhang, Yingxin Yang
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 11 (2024)
Introduction: Cancer remains a significant health challenge, with chemotherapy being a critical treatment modality. However, traditional chemotherapy faces limitations due to non-specificity and toxicity. Nanogels, as advanced drug carriers, offer po
Externí odkaz:
https://doaj.org/article/6e99ccd74935444888713ee3446e147b
Autor:
Yuexiao Li, Minda Liu, Mingyu Xue, Yuanyuan Kang, Dongjuan Liu, Yan Wen, Duoyi Zhao, Boyu Guan
Publikováno v:
Molecules, Vol 28, Iss 17, p 6373 (2023)
Dental caries is the most prevalent chronic disease globally, significantly impacting individuals’ quality of life. A key reason behind the failure of implanted restorations is their biological inactivity, meaning they are unable to form crosslinks
Externí odkaz:
https://doaj.org/article/226a53c113cc473a8e52e86ea221d078
Autor:
Qiushuang Sheng, Xiaoning Hou, Nan Wang, Minda Liu, Haoyu Zhu, Xuming Deng, Xiaoying Liang, Gefu Chi
Publikováno v:
Molecules, Vol 27, Iss 16, p 5063 (2022)
Pneumolysin (PLY) is a significant virulence factor of Streptococcus pneumoniae (S. pneumoniae), able to break through the defense system of a host and mediate the occurrence of a series of infections. Therefore, PLY as the most ideal target to preve
Externí odkaz:
https://doaj.org/article/868ec736c42b4cc1b333fceb201158d3
Autor:
Pai Pang, Hui Fang, Hong Wu, Song Wang, Minda Liu, Shan Jin, Zhongzheng Qi, Zhenning Li, Fayu Liu, Changfu Sun
Publikováno v:
Bioengineered, Vol 12, Iss 2, Pp 11397-11409 (2021)
Bioengineered
article-version (VoR) Version of Record
Bioengineered
article-version (VoR) Version of Record
In this study we report a novel specificity protein 1 (SP1)/microRNA-92b (miR-92b) feedback loop regulating the migration and invasion of head and neck squamous cell carcinoma (HNSCC). Microarray and real-time Polymerase Chain Reaction (PCR) were use
Autor:
Minda Liu, Qianghua Lv, Jingwen Xu, Baichen Liu, Yonglin Zhou, Siqi Zhang, Xue Shen, Lin Wang
Publikováno v:
Biochemical Pharmacology. 209:115447
Autor:
Qiushuang Sheng, Xiaoning Hou, Baichen Liu, Yang Wang, Nan wang, Runbao Du, Minda Liu, Haoyu Zhu, Xuming Deng, Zhongmei Wen, Dan Li, Li Li, Yonglin Zhou, Jianfeng Wang
Publikováno v:
SSRN Electronic Journal.
Autor:
Emily Sanville, Megan Tipps, Amy Ellenberger, Minda Liu, Nilanjana Banerji, Kelsey Jackson, Meghan Hultman, John Trusheim
Publikováno v:
Neuro Oncol
INTRODUCTION Standard care for glioblastoma consists of maximal surgical resection followed by radiotherapy with concurrent and adjuvant temozolomide. Fatigue and sleep disturbances are among the most common side-effect reported by these patients. Mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c0ad7429508bb6428a6a1fe74ee9dcf
https://europepmc.org/articles/PMC6847257/
https://europepmc.org/articles/PMC6847257/
Publikováno v:
Neuro Oncol
INTRODUCTION Glioblastoma is the most common primary malignant brain tumor, with an annual incidence of 3–4 new cases per 100,000 people. Despite advances in chemotherapy, radiotherapy, and surgical interventions, prognosis remains poor. Aims of tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a8b2334430ccb747c8ebcbc52618645
https://europepmc.org/articles/PMC6847620/
https://europepmc.org/articles/PMC6847620/
Publikováno v:
International Journal of Cancer. 141:1389-1401
Pancreatic cancer shows a remarkable predilection for hepatic metastasis. Complement component 1, q subcomponent binding protein (C1QBP) can mediate growth factor-induced cancer cell chemotaxis and distant metastasis by activation of receptor tyrosin
Publikováno v:
Neuro Oncol
INTRODUCTION Standard care for newly diagnosed glioblastoma consists of maximal surgical resection followed by radiotherapy with concurrent and adjuvant temozolomide. Prognosis for glioblastoma still remains poor, with a reported median survival of 1